Latest CD134 Stories
Glenmark's Novel Monoclonal Antibody GBR 830 for Treatment of Autoimmune Diseases Entering Human Trials
MUMBAI,India, July 3, 2014 /PRNewswire/ -- - GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of
Cancers arise in the body all the time.
Word of the Day
- An imitative word; an onomatopoetic word.
The word 'onomatope' is a back-formation from 'onomatopoeia'.